Skip to main content

Advertisement

Log in

Exposition to chickenpox of two children with autoinflammatory syndromes under treatment with anakinra

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

We report two children with autoinflammatory syndromes treated with anakinra who came in contact with the varicella-zoster virus after being exposed accidentally to infected children: both cases were managed prophylactically with specific antichickenpox intravenous immunoglobulins and anakinra temporary suspension; neither adverse events nor complications related to the natural course of chickenpox were experienced by the two patients. The risk of developing infectious events should be closely monitored, because of the absence of data concerning long-term safety of biological agents in the pediatric age, and prevention strategies should be highly encouraged before they are started.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Grateau G, Granel B, Hengen V, Dode C, Cuisset L, Delpeche M (2004) Hereditary intermittent fever. Presse Med 33:1195–2206

    Article  PubMed  Google Scholar 

  2. Arav-Borger R, Spirer Z (1997) Periodic syndromes of childhood. Adv Pediatr 44:389–428

    Google Scholar 

  3. Ozen S (2001) A new insight into periodic and recurrent fever. Clinical aspects and differential diagnosis of periodic fever syndromes. Riv Ital Pediatr 27:616–617

    Google Scholar 

  4. School PR (2000) Periodic fever syndromes. Curr Opin Pediatr 12:563–566

    Article  Google Scholar 

  5. John CC, Gilsdorf JR (2002) Recurrent fever in children. Pediatr Infect Dis 21:1071–1077

    Article  Google Scholar 

  6. Majeed HA (2000) Differential diagnosis of fever of unknown origin in children. Curr Opin Rheumatol 12:439–444

    Article  PubMed  CAS  Google Scholar 

  7. Frenkel J, Kuis W (2002) Overt and occult rheumatic diseases: the child with chronic fever. Best Pract Res Clin Rheumatol 16:443–469

    PubMed  Google Scholar 

  8. Estlin EJ (2002) Novel targets for therapy in paediatric oncology. Curr Drug Targets Immune Endocr Metabol Disord 2:141–150

    Article  PubMed  CAS  Google Scholar 

  9. Chira P, Sandborg CI (2003) Novel therapies in pediatric rheumatic diseases. Curr Opin Pediatr 15:579–585

    Article  PubMed  Google Scholar 

  10. Wilkinson N, Jackson G, Gardner-Medwin J (2003) Biological therapies for juvenile arthritis. Arch Dis Child 88:186–191

    Article  PubMed  CAS  Google Scholar 

  11. Dinarello CA, Wolff SM (1993) The role of interleukin-1 in disease. N Engl J Med 328:106–113

    Article  PubMed  CAS  Google Scholar 

  12. Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW (1988) Correlation of plasma interleukin-1 levels with disease activity in rheumatoid arthritis. Lancet 2:706–708

    Article  PubMed  CAS  Google Scholar 

  13. Arend WP, Malyak M, Guthridge CJ, Gabay C (1998) Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 16:27–55

    Article  PubMed  CAS  Google Scholar 

  14. Carrasco R, Smith JA, Lovell D (2004) Biologic agents for the treatment of juvenile rheumatoid arthritis: current status. Paediatr Drugs 6:137–146

    Article  PubMed  Google Scholar 

  15. McDermott MF, Aksentijevich I (2002) The autoinflammatory syndromes. Curr Opin Allergy Clin Immunol 2:511–516

    Article  PubMed  Google Scholar 

  16. Konttinen L, Kankaanpaa E, Luosujarvi R, Blafield H, Vuori K, Hakala M, Rantalaiho V, Savoilanen E, Uutela T, Nordstrom D, ROB-FIN Study Group (2006) Effectiveness of anakinra in rheumatic disease in patients naïve to biological drugs or previously on TNF blocking drugs: an observational study. Clin Rheumatol 25:882–884

    Article  PubMed  Google Scholar 

  17. Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN (2006) The comparative efficacy and safety of biologics for the treatment of rheumatoid arthritis: systematic review and metaanalysis. J Rheumatol 33:2398–2408

    PubMed  CAS  Google Scholar 

  18. Callen JP (2007) Complications and adverse reactions in the use of newer biologic agents. Semin Cutan Med Surg 26:6–14

    Article  PubMed  CAS  Google Scholar 

  19. Ziebold C, von Kries R, Lang R, Weigl J, Schmitt HJ (2001) Severe complications of varicella in previously healthy children in Germany: a 1-year survey. Pediatrics 108:e79

    Article  PubMed  CAS  Google Scholar 

  20. Grimprel E, Levy C, de La Rocque F, Cohen R, Soubeyrand B, Caulin E, Derrough T, Lecuyer A, d’Athis P, Gaudelus J (2007) Paediatric varicella hospitalisation in France: a nationwide survey. Clin Microbiol Infect 13:546–549

    Article  PubMed  CAS  Google Scholar 

  21. Lovell DJ, Giannini EH, Reiff A, Jones OY, Schneider R, Olson JC, Stein LD, Gedalia A, Ilowite NT, Wallace CA, Lange M, Finck BK, Burge DJ, Pediatric Rheumatology Collaborative Study Group (2003) Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis: interim results from an ongoing multicenter, open-label, extended-treatment trial. Arthritis Rheum 48:218–226

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Donato Rigante.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rigante, D., Ansuini, V., Berrettini, A. et al. Exposition to chickenpox of two children with autoinflammatory syndromes under treatment with anakinra. Rheumatol Int 28, 793–796 (2008). https://doi.org/10.1007/s00296-007-0515-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0515-2

Keywords

Navigation